Poland · Delayed Price · Currency is PLN genXone Company Description
genXone S.A., a biotechnology company, provides nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.
The company offers whole genome, metagenome, shotgun metagenomic, plasmid DNA, and transcriptome sequencing services, as well as bioinformatic analysis.
It also provides nucleic acid isolation; molecular diagnostics laboratory; and operates in the field of molecular genetics and bioinformatics.
In addition, the company develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture.
genXone S.A. was incorporated in 2018 and is headquartered in Suchy Las, Poland.
| Country | Poland |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Michal Kaszuba |
Contact Details
Address: ul. Kobaltowa 6 Suchy Las, 62-002 Poland | |
| Phone | 48 888 60 23 08 |
| Website | genxone.eu |
Stock Details
| Ticker Symbol | GX1 |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLGENXN00013 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Michal Kaszuba | President of the Management Board |
| Anna Strumnik | Vice President of the Management Board |